Drugs / cortivazol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/31 trial · 1 met primary | ||||||
| Phase 2/3 | NCT00804895 | Dec 2008 → Oct 2009 | cluster headache syndrome | Assistance Publique - Hôpitaux de Paris | Completed | Met primary |
| Comparator or background therapy1 trial | ||||||
| — | NCT03857334 Comparator | Jul 2016 → Oct 2017 | plantar fasciitis | University Hospital, Montpellier | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | cortivazol | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00804895 ↗ |
| Known as | Altim | “Injection of cortivazol : Altim®” NCT03857334 ↗1“ALTIM, cortivazol injections” NCT00804895 ↗ |
| Modality | Other / unclassified | “Corticosteroids” NCT03857334 ↗ |
| Route | Subcutaneous | “subcutaneous injection of Cortivazol ALTIM, 3,375mg” NCT00804895 ↗ |